ISO 13485:2016 certified · Startup India (DPIIT) recognised · NVIDIA Inception program member +91 44 4690 0555info@medoqi.tech
Home/Global markets/United Kingdom
Europe · United Kingdom

Place your device on the Great Britain market with the right marking and registration.

CE or UKCA routes, UK Responsible Person coordination and MHRA registration, with the post-market requirements that now apply in Great Britain.

Regulatory overview

Key facts

AuthorityMedicines and Healthcare products Regulatory Agency (MHRA); UK Approved Bodies
LegislationUK Medical Devices Regulations 2002, as amended
Device classesClass I, IIa, IIb, III
IVD classesGeneral, List A, List B and self-test
Quality systemISO 13485; Approved Body assessment where required
Local representationUK Responsible Person for non-UK manufacturers
Market authorisation

Pathways

  • CE-marked devices accepted in Great Britain under transitional arrangements, with end dates that depend on the legislation the device meets
  • UKCA marking through a UK Approved Body, or self-declaration for Class I and general IVDs
  • Registration with the MHRA before placing devices on the GB market
  • Northern Ireland follows the EU MDR and IVDR
Documentation

What you will need

  • Technical documentation and declaration of conformity
  • Certificates from an EU Notified Body or UK Approved Body as applicable
  • UK Responsible Person details on labelling where required
  • Registration information for the MHRA
Registration process

Sequence and decision points

  1. 01Choose the routeCE reliance under transitional arrangements, or UKCA marking.
  2. 02Appoint a UK Responsible PersonRequired for manufacturers based outside the UK.
  3. 03Conformity assessmentUK Approved Body assessment where the class requires it.
  4. 04Register with the MHRADevices registered before they are placed on the market.
  5. 05MonitorVigilance reporting and GB post-market surveillance.
Quality system

ISO 13485 is the designated standard. Approved Body or Notified Body QMS assessment applies above Class I and general IVDs.

Local representation

Manufacturers outside the UK must appoint a UK Responsible Person for Great Britain.

Where MedoQi does not hold this role, we work with your appointed representative or a qualified partner.

Timelines and fees

MHRA registration fees are published by the MHRA, and Approved Body timelines vary. Transitional dates for CE-marked devices differ by device type and legislation; confirm them against current MHRA guidance.

Post-market obligations

After market entry

  • Vigilance and field safety reporting to the MHRA
  • GB post-market surveillance requirements, in force since 16 June 2025
  • Registration updates when devices or details change
MedoQi services

How we help

  • GB route strategy: CE reliance or UKCA
  • UK Responsible Person coordination
  • MHRA registration support
  • UKCA technical documentation
  • GB post-market surveillance and vigilance

Delivered through our model: assess, validate, remediate, submit, maintain. How we work

FAQ

Common questions about United Kingdom

Summary information for orientation. Requirements depend on intended use, classification and device characteristics, and change over time.

Can we keep selling CE-marked devices in Great Britain?

Yes, for now, under transitional arrangements. The end dates depend on whether the device meets the MDD, IVDD, MDR or IVDR, so plan your longer-term route early.

What applies in Northern Ireland?

Northern Ireland follows the EU MDR and IVDR.

Talk to our experts

Discuss your device, market or audit with a specialist

Share the device, its class and your target markets. A senior specialist will come back with the likely pathway, the evidence gaps we see and a practical plan.

Talk to our experts → Request an AI pilot sales@medoqi.tech · +91 44 4690 0555